Zobrazeno 1 - 10
of 23
pro vyhledávání: '"François Fabi"'
Autor:
Laurence Morin, Louis-Philippe Grenier, Nicolas Foucault, Éric Lévesque, François Fabi, Eve-Lyne Langlais, Alexandra Sebastianelli, Marianne Lavoie, Marc Lalancette, Marie Plante, Mahukpe Narcisse Ulrich Singbo, Vincent Castonguay
Publikováno v:
Current Oncology, Vol 31, Iss 8, Pp 4624-4631 (2024)
Weekly paclitaxel (WP) is a chemotherapeutic cornerstone in the management of patients with platinum-resistant ovarian carcinoma. Multiple WP dosing regimens have been used clinically and studied individually. However, no formal comparison of these r
Externí odkaz:
https://doaj.org/article/a676d5b9c983478eacedf9d38891e071
Autor:
François Fabi, Ève Chamberland, Myreille D’Astous, Karine Michaud, Martin Côté, Isabelle Thibault
Publikováno v:
Current Oncology, Vol 31, Iss 7, Pp 3968-3977 (2024)
Background: Cystic, sporadic hemangioblastomas (HBLs) represent a unique, therapeutically challenging subset of central nervous system tumors, mainly due to their unpredictable growth patterns and potential for symptomatic progression. This study aim
Externí odkaz:
https://doaj.org/article/a8732d4232f74bd2b91fd5bbb290e9a7
Publikováno v:
Current Oncology, Vol 31, Iss 7, Pp 3758-3770 (2024)
Background: Serous endometrial carcinoma (SEC) is a high-risk subtype of endometrial cancer. The effectiveness of multiple adjuvant therapies, namely chemotherapy (CT), radiotherapy (RT), and sequential/concurrent chemotherapy with radiotherapy (CRT)
Externí odkaz:
https://doaj.org/article/ab8b37f9d6264955974e7913d8bce53b
Publikováno v:
Molecular Oncology, Vol 15, Iss 8, Pp 2106-2119 (2021)
The PI3K/Akt signaling pathway, the most frequently altered signaling system in human cancer, is a crucial inducer of dysregulated proliferation and neoplastic processes; however, few therapeutic strategies using PI3K/Akt inhibitors singly have been
Externí odkaz:
https://doaj.org/article/ff97c07ff94349dea3d0a80534f27624
Autor:
François Fabi, Pascal Adam, Keven Vincent, Françis Demontigny, Sophie Parent, France-Hélène Joncas, Eric Asselin
Publikováno v:
Cell Communication and Signaling, Vol 16, Iss 1, Pp 1-16 (2018)
Abstract Background CRM1 enrichment has been shown to be indicative of invasive as well as chemoresistant tumors. On the other hand, TRAIL, a powerful and specific anti-tumoral agent, has yet to be used effectively to treat gynecological tumors in pa
Externí odkaz:
https://doaj.org/article/ac5d3163bb294427b77267ec0adf6f34
Autor:
François Fabi, Kathy Grenier, Sophie Parent, Pascal Adam, Laurence Tardif, Valérie Leblanc, Eric Asselin
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0177387 (2017)
Infertility is constantly increasing in Canada, where 16% of Canadian couples are experiencing difficulty conceiving. It is thought that infertility can emanate from the dysregulated communication between the embryo and the maternal endometrium. In o
Externí odkaz:
https://doaj.org/article/090871a051ce432e99ca42a0e5ac3ba2
Autor:
Pascal Adam, Laurence Tardif, François Fabi, Dadou Likonza Lokengo, Léa-Isabelle Renaud, Sophie Parent, Monique Cadrin, Derek Boerboom, Eric Asselin
Publikováno v:
Reproduction. 165:605-616
In brief The regulation of AKT in the endometrium during many cellular processes such as apoptosis and cell survival is crucial during the estrous cycle to ensure fertility. This research shows the specific function of AKT isoforms in the mouse endom
Publikováno v:
Global Ecology and Conservation, Vol 52, Iss , Pp e02939- (2024)
Common reed (Phragmites australis), an exotic invasive plant in North America, alters wetlands and thus affects the abundance, development and behavior of many animal species. We evaluated the effect of common reed invasion on 1) the abundance of noc
Externí odkaz:
https://doaj.org/article/0f6eda93ee4647d6b088ea4defef1399
Publikováno v:
Tumor Suppressor Par-4 ISBN: 9783030805579
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba2857a4135960c22c3c5b3945e0cae3
https://doi.org/10.1007/978-3-030-80558-6_3
https://doi.org/10.1007/978-3-030-80558-6_3